期刊文献+

甲巯咪唑致严重粒细胞缺乏2例并严重不良反应文献分析

Literature analysis of 2 cases of severe agranulocytosis caused by methimazole and serious adverse reactions
下载PDF
导出
摘要 目的分析甲巯咪唑致严重不良反应,为临床安全用药提供参考。方法基于湖北民族大学附属民大医院发生的甲巯咪唑致严重粒细胞缺乏患者2例,检索CNKI、万方、pubmend等数据库,查阅甲巯咪唑导致的严重不良反应病例,分析其表现及可能存在的原因。结果甲巯咪唑致严重不良反应主要集中在血液系统、骨和关节系统、消化系统、皮肤等,主要表现为粒细胞缺乏、肝功能受损、大泡性皮疹、关节痛、抽搐、罕见间质性肺炎等。结论甲巯咪唑致严重不良反应不容忽视,临床使用时应严密监测血常规、肝肾功能、肌酸激酶等,对患者宣传用药安全知识,加强自我监测,以确保用药安全。 Objective To analyze the serious adverse reactions caused by methimazole and provide some reference for clinical safety.Methods Based on 2 patients with severe agranulocytosis caused by methimazole in the Minda Hospital affiliated to Hubei Minzu University.Databases such as CNKI,Wanfang and Pubmend were searched for cases of severe adverse reactions caused by methimazole,and their manifestations and possible causes were analyzed.Results Severe adverse reactions caused by methimazole were mainly concentrated in the blood system,bone and joint system,digestive system,skin,etc.,mainly manifested as agranulocytosis,impaired liver function,bullous rash,joint pain,convulsions,and rare interstitial Pneumonia etc.Conclusion Serious adverse reactions caused by methimazole should not be ignored.During clinical use,blood routine,liver and kidney function,creatine kinase,etc.,should be closely monitored,and drug use should be well confessed and self-monitoring should be strengthened to ensure the safety of drug use.
作者 李红玲 张军 庄红玲 谭娜 LI Hongling;ZHANG Jun;ZHUANG Hongling(Department of Pharmacy,Minda Hospital Affiliated to Hubei Minzu University,Hubei Province,Enshi 445000,China)
出处 《临床合理用药杂志》 2020年第25期15-17,20,共4页 Chinese Journal of Clinical Rational Drug Use
关键词 甲巯咪唑 粒细胞缺乏 药物不良反应 文献分析 Methimazole Agranulocytosis Adverse reactions Literature analysis
  • 相关文献

参考文献12

二级参考文献47

  • 1沈杨,沈濬,陈钰,曾晓颖,李军民,倪语星,沈志祥.血液肿瘤合并感染病原菌流行病学及耐药性研究[J].中华血液学杂志,2004,25(6):328-332. 被引量:26
  • 2徐琴英,闵月,王小鹏,李晓忠.抗甲状腺药物致儿童急进性肾小球肾炎[J].实用儿科临床杂志,2006,21(19):1338-1340. 被引量:6
  • 3Bo Li,Zhi Wang,Jian-Jiang Fang,Ci-Yi Xu,Wei-Xing Chen.Evaluation of prognostic markers in severe drug-induced liver disease[J].World Journal of Gastroenterology,2007,13(4):628-632. 被引量:13
  • 4白耀,主编.甲状腺病学[M].北京:科学技术文献出版社,2004.4.
  • 5BARTALENA L, BOGAZZI F, MARTINO E. Adverse effects of thyroid hormone preparations and antithyroid drugs[ J]. Drug Saf, 1996, 15(1) :53 -63.
  • 6WING S S, FANTUS I G. Adverse immunologic effects of antithyroid drugs[ J]. Can Med Associ J, 1987,136(2) : 121 - 127.
  • 7TSUBOI K, UESHIBA H, SHIMOJO M,et al. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves disease[ J]. Endocrine J,2007, 54(1) :39 -43.
  • 8REINWEIN D, BENKER G, LAZARUS J H, et al. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment [J]. J Clin Endocrinol Metab, 1993,76(6) :1516 -1521.
  • 9高妍.抗甲状腺药物应用的现状与困惑[N].中国医学论坛报,2010-9-2,(A8).
  • 10姜晓华,顾卫琼,宁光.甲亢伴发热、白细胞减少[N].中国医学论坛报,2010-2-4,(A8).

共引文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部